Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1401775

registered interest
date	11/01/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when his Department plans to publish an updated covid-19 vaccine delivery plan.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	101717
answer	answer is ministerial correction date of answer 19/01/2022 answer text <p>There are no current plans to publish an updated COVID-19 Vaccine Delivery Plan.</p><p>As of 12 January 2022, over 83% of those aged 12 years old and over in the United Kingdom have received two doses of the vaccine, and over 90% have received one dose. Over 365 million people have received a booster or third primary dose. The Joint Committee on Vaccination and Immunisation has advised that there is no immediate need to introduce a second booster or fourth dose to the most vulnerable. The timing and need for any potential further booster doses will be reviewed.</p><p> </p> answering member constituency Erewash answering member printed Maggie Throup question first answered 19/01/2022 13:45:03 answering member 4447 label Biography information for Maggie Throup
tabling member	4131 label Biography information for Jim Shannon

1401468

registered interest
date	10/01/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Disease Control
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure long-term immune monitoring of people who have contracted the omicron covid-19 variant.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	100547
answer	answer is ministerial correction date of answer 20/01/2022 answer text <p>There are several ongoing studies on the immunity to COVID-19 conferred by prior infection. An assessment of long-term immunity in those who have contracted the Omicron variant will be included as evidence emerges over time. Since June 2020, the SIREN study has assessed, through serial antibody and swab testing, the protection granted by prior infection and vaccination in a large cohort of healthcare workers.</p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 100504 question first answered 20/01/2022 09:47:29 answering member 4447 label Biography information for Maggie Throup
tabling member	4131 label Biography information for Jim Shannon

1401471

registered interest
date	10/01/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential need for a fourth covid-19 vaccine dose.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	100549
answer	answer is ministerial correction date of answer 18/01/2022 answer text <p>On 7 January 2022, the Joint Committee on Vaccination and Immunisation (JCVI) advised that the priority for the COVID-19 booster programme remains to increase coverage of the first booster dose across the adult population, particularly in older adults and those in clinical risk groups. A second booster dose was not advised at this time, as there is evidence of continued high vaccine effectiveness against hospitalisation due to the Omicron variant following a first booster dose. The JCVI continues to consider the latest available data and its review of the booster programme, particularly in relation to the timing and value of any second booster doses for the most vulnerable.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 18/01/2022 16:34:02 answering member 4447 label Biography information for Maggie Throup
tabling member	4131 label Biography information for Jim Shannon

1399763

registered interest
date	05/01/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia and Heart Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether there has been a relative increase in the numbers of people diagnosed with (a) dementia and (b) heart disease over the last 18 months.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	98283
answer	answer is ministerial correction date of answer 14/01/2022 answer text <p>There has been a decrease in the numbers of people diagnosed with dementia and heart disease in the last 18 months. The reduction in the numbers of people diagnosed with dementia and heart disease can be attributed to the impact of COVID-19.</p><p>The number of people registered to with a general practitioner (GP), the data shows that 0.72% were diagnosed with dementia in November 2021, compared to 0.73% in June 2020. This coincided with a reduction of 25% in referrals from GPs to memory clinics. There has been a reduction of 0.04% in the number of people diagnosed with heart disease in England in the last 18 months.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 14/01/2022 13:43:11 answering member 4362 label Biography information for Edward Argar
tabling member	4131 label Biography information for Jim Shannon

1399764

registered interest
date	05/01/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Negligence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 September 2021 to Question 43518 on NHS: Negligence, how much NHS Resolution spent on medication errors in (a) hospitals and (b) GP surgeries in the financial year 2020-21.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	98284
answer	answer is ministerial correction date of answer 11/01/2022 answer text <p>The information is not held in the format requested as NHS Resolution indemnify their members under various schemes between primary and secondary care. However, the following table shows the total value of payments made by NHS Resolution for damages and legal costs for medication errors in secondary care and primary care in England in 2020/21.</p><p> </p><table><tbody><tr><td><p>Type</p></td><td><p>Damages paid</p></td><td><p>National Health Service legal costs</p></td><td><p>Claimant legal costs</p></td><td><p>Total costs</p></td></tr><tr><td><p>Secondary care</p></td><td><p>£5,773,001</p></td><td><p>£839,761</p></td><td><p>£10,155,919</p></td><td><p>£16,768,681</p></td></tr><tr><td><p>Primary care</p></td><td><p>£38,140</p></td><td><p>£13,792</p></td><td><p>£63,541</p></td><td><p>£115,474</p></td></tr></tbody></table> answering member constituency Lewes answering member printed Maria Caulfield question first answered 11/01/2022 11:56:13 answering member 4492 label Biography information for Maria Caulfield
tabling member	4131 label Biography information for Jim Shannon

1399765

registered interest
date	05/01/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Xenotransplantation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether any operations have taken place using animal organs specifically for transplants in the UK.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	98285
answer	answer is ministerial correction date of answer 11/01/2022 answer text <p>NHS Blood and Transplant has a statutory duty to match and allocate organs for transplant to hospitals within the United Kingdom. All organs supplied for transplant come from deceased or living human donors.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 11/01/2022 16:18:43 answering member 4492 label Biography information for Maria Caulfield
tabling member	4131 label Biography information for Jim Shannon

1399766

registered interest
date	05/01/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Fatigue Syndrome: Exercise
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to NICE's updated guidance on exercise for sufferers of ME, whether his Department has plans to promote that information to health and social care staff.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	98286
answer	answer is ministerial correction date of answer 17/01/2022 answer text <p>The National Institute for Health and Care Excellence is working with the National Health Service to support the implementation of its guidance. While the guidance describes best practice and should be taken into account in the treatment of patients, it is not mandatory and does not override a medical practitioner’s clinical judgement.</p> answering member constituency Chichester answering member printed Gillian Keegan question first answered 17/01/2022 14:13:34 answering member 4680 label Biography information for Gillian Keegan
tabling member	4131 label Biography information for Jim Shannon

1399767

registered interest
date	05/01/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has a timetable for the HIV drug which combines the antiretroviral drugs cabotegravir and rilpivirine as a bi-monthly injection to be available on the NHS throughout the UK.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	98287
answer	answer is ministerial correction date of answer 12/01/2022 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing evidence-based recommendations for the National Health Service on whether new medicines represent a clinically and cost-effective use of resources. On 5 January 2022, NICE published guidance recommending cabotegravir with rilpivirine, within its marketing authorisation, as an option for treating HIV‑1 infection in adults. The guidance is available at the following link:</p><p><a href="https://www.nice.org.uk/guidance/ta757" target="_blank">https://www.nice.org.uk/guidance/ta757</a></p><p>The NHS in England is legally required to fund medicines recommended in a NICE appraisal within three months of final guidance. The availability of medicines in the rest of the United Kingdom is a devolved matter.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 12/01/2022 16:34:16 answering member 4362 label Biography information for Edward Argar
tabling member	4131 label Biography information for Jim Shannon

1399777

registered interest
date	05/01/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what his timetable is for conclusion of the pilot of the closed loop technology to continually monitor blood glucose and adjust insulin given for type one diabetics; and what estimate he has made of when that technology will be widely available to all suitable type one diabetics.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	98295
answer	answer is ministerial correction date of answer 14/01/2022 answer text <p>NHS England and NHS Improvement are currently collecting data on the use of closed loop systems as part of the hybrid closed loop pilot. The data collected is due to be analysed in April 2022. The findings will be shared with the National Institute for Health and Care Excellence (NICE) to inform a multiple technology appraisal. The outcome of this appraisal is expected in autumn 2022. This will determine whether the technology will be offered in the National Health Service and which patients it is recommended for. If recommended by NICE, trusts would be expected to routinely offer the technology within six months of the publication of the guidance.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 14/01/2022 13:31:50 answering member 4492 label Biography information for Maria Caulfield
tabling member	4131 label Biography information for Jim Shannon

1399847

registered interest
date	05/01/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Eating Disorders: Children and Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of providing dedicated facilities to treat children and young people with eating disorders at specialised hubs placed throughout the UK.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	98298
answer	answer is ministerial correction date of answer 17/01/2022 answer text <p>We have made no such assessment. We have provided additional funding for children and young people's community eating disorder services, with £53 million per year from 2021/22.</p><p>This will enhance the capacity of the 70 new or improved community eating disorder teams in England.</p><p> </p><p>NHS England and NHS Improvement have also announced a further £40 million in 2021/22 to address the impact of the pandemic on children and young people’s mental health, including eating disorders. Of this, £10 million of capital funding is providing additional beds at units for young people with the most complex needs, including eating disorders, £1.5 million to ensure there are additional facilities for children under 13 years old.</p> answering member constituency Chichester answering member printed Gillian Keegan question first answered 17/01/2022 11:32:02 answering member 4680 label Biography information for Gillian Keegan
tabling member	4131 label Biography information for Jim Shannon